Precision NanoSystems
Latest round
- Series B
Last raised
- May 2018
Total raised
- $19M
Investors
- 3
About Precision NanoSystems
Based in Vancouver, Canada, and founded in 2010, Precision NanoSystems Inc. provides medical tools and processes for medicines and medical research.D.D. as its Chief Comercial Officer. The company provides NanoAssemblr™ transfection reagents that use nanomedicine technology to deliver genetic materials in primary cells in vitro and in vivo. The firm's NanoAssemblr™ platform allows the reproducible manufacture of nanoparticle formulations for the delivery of nucleic acids, drug molecules, and diagnostic agents to cells and tissues in the body.
Who invested in Precision NanoSystems
3 investors across 2 rounds
See all investors in Precision NanoSystems
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Precision NanoSystems
Who invested in Precision NanoSystems?
Precision NanoSystems has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Precision NanoSystems raised?
Precision NanoSystems has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Precision NanoSystems last raise money?
Precision NanoSystems's most recent round on record is a Series B, in May 2018.
What does Precision NanoSystems do?
Based in Vancouver, Canada, and founded in 2010, Precision NanoSystems Inc.
Where is Precision NanoSystems headquartered?
Precision NanoSystems is headquartered in Vancouver, Canada.
Which VCs invest in companies like Precision NanoSystems?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Precision NanoSystems's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Precision NanoSystems? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.